In the US, extracts cannabidiol on the list of especially dangerous narcotic drugs, turnover of which is prohibited
-700x540.jpg)
Another "do not run" national industry, aimed at medical use of industrial hemp, are trying to destroy the outside in the bud.
Drug Enforcement Administration (Drug Enforcement Administration, DEA) has made the US containing extracts of cannabidiol (CBD) to the list of illegal drugs that are prohibited for use in medicine.
The substance, which has for many years used the country as a remedy for epilepsy, and has positive feedback not only from doctors, but also by some of the employees of the Office, this equates to particularly dangerous drugs like heroin or cocaine.
On the basis of the new interpretation of the proposed changes to the current US law, now under the extracts of cannabis mean: "any oil extracted from the Cannabis plant family, containing a variety of cannabinoids."
In other words - the above state structure had full control over the scientists and doctors who are engaged in studies of the therapeutic properties of extracts containing CBD. Now, for the research will be required to obtain a special permit that is designed exclusively for use with extracts, not a license to study hemp.
In his interview with the media representative of the US DEA Russ Baer he said that such a measure is a kind of internal reporting mechanism for the implementation of control of the achievements of science in the field of application of cannabidiol research for therapeutic purposes.
Unfortunately, the new legal act the US DEA can significantly slow down the work of scientists studying the therapeutic properties of cannabis. For example, the antiepileptic drug Epidiolex containing CBD, developed by the British firm GW Pharmaceuticals and aimed at combating Draveta Syndrome, has reached a stage of approval US sanitary control service. In a very short period of time, oil containing CBD could go into wide production.
Robert Hoban on hemp business lawyer in Colorado and the University of Denver law professor believes that in this case the Drug Enforcement Administration has exceeded its powers, since the activities of this government structure is monitoring compliance with existing laws, rather than to develop new ones. Lawyer confident that DEA officers had invented a new category of substances called "cannabis extracts" and ascribed them to the drugs. The goal is obvious - the unconditional control over hemp. Mr Hoban sure that in this way all existing cannabinoids were "substances that have no therapeutic use," despite the existing evidence of their effectiveness, as well as designed to use this rule.
In any case, the US DEA has determined for itself that extracts containing cannabidiol refer to drugs. Time will tell how these innovations will stand against the existing criticism and undisguised discontent on the part of patients, has long been using beznarkoticheskie cannabinoids for the treatment of severe, including chronic diseases.
Comment of the Association "Ukrainian industrial hemp"
Similar processes initiated in Germany, the United Kingdom and the United States similar to those that are already in the 30s of the last century were provoked by private US companies to discredit the hemp industry. Again repeated situation where unfounded blaming easy availability transformation beznarkoticheskih cannabinoids THC, some pharmaceutical companies are economically developed countries of the world have initiated research company administration and sales while only cannabidiol. On the territory of our country have traced similar processes when state structures imposed concern the possibility of creating facilities that can satisfy the domestic market of Ukraine with quality and cheap drugs on the basis of beznarkoticheskih cannabinoids. Another "do not run" national industry, aimed at medical use of industrial hemp, are trying to destroy the outside in the bud.
Information taken from the site http://tku.org.ua